Crossmark

Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide

Crossref DOI link: https://doi.org/10.1007/s00277-021-04439-6

Published Online: 2021-02-12

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kurita, Naoki https://orcid.org/0000-0002-1283-4307
Sakamoto, Tatsuhiro

Kato, Takayasu

Kusakabe, Manabu

Yokoyama, Yasuhisa

Nishikii, Hidekazu

Sakata-Yanagimoto, Mamiko

Obara, Naoshi

Hasegawa, Yuichi

Chiba, Shigeru
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP15Aek0510005)
License Information

Text and Data Mining valid from 2021-02-12

Version of Record valid from 2021-02-12
More Information

Article History

Received: 13 August 2020

Accepted: 20 January 2021

First Online: 12 February 2021

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board of University of Tsukuba Hospital (approval #H23-081 and #H26-184). Informed consent was obtained from all individual participants included in the study.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below